Prime Capital Investment Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Prime Capital Investment Advisors's IDXX Position: Q2 2026 in Review
Prime Capital Investment Advisors increased its Idexx Laboratories (IDXX) stake by 1.2% in Q2 2026, buying an estimated $26.4K and bringing the position to 3,952 shares worth $2.08M. The position accounts for 0.02% of the portfolio, ranked #374.
Prime Capital Investment Advisors first reported a position in IDXX in Q4 2018 and has held it in 13 quarters since. The position peaked at $3.61M in Q4 2023. 897 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Prime Capital Investment Advisors held 3,952 shares of Idexx Laboratories worth $2.08M as of Q2 2026.
- Prime Capital Investment Advisors bought 47 Idexx Laboratories shares in Q2 2026, an estimated $26.4K.
- Idexx Laboratories made up 0.02% of Prime Capital Investment Advisors's portfolio in Q2 2026, its #374 holding.
- Prime Capital Investment Advisors first reported a position in Idexx Laboratories in Q4 2018 and has held it in 13 quarters since.
- Prime Capital Investment Advisors's Idexx Laboratories position peaked at $3.61M in Q4 2023.
- 897 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Prime Capital Investment Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.